SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001387131-22-001752
Filing Date
2022-02-14
Accepted
2022-02-14 06:11:17
Documents
2
Group Members
ALTIUM GROWTH FUND, LPALTIUM GROWTH GP, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SC 13G uncy_sc13ga-123121.htm SC 13G/A 86072
2 JOINT ACQUISITION STATEMENT ex-1.htm EX-1 8917
  Complete submission text file 0001387131-22-001752.txt   96518
Mailing Address 152 W 57 ST FL20 NEW YORK NY 10019
Business Address 152 W 57 ST FL20 NEW YORK NY 10019 2124842711
Altium Capital Management LP (Filed by) CIK: 0001746382 (see all company filings)

IRS No.: 822066653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022
Business Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Subject) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92874 | Film No.: 22624558
SIC: 2834 Pharmaceutical Preparations